{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:38:26Z","timestamp":1788345506984,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","award":["1K23HL151826"],"award-info":[{"award-number":["1K23HL151826"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R01AI120938"],"award-info":[{"award-number":["R01AI120938"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["R01AI128779"],"award-info":[{"award-number":["R01AI128779"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["T32AI102623"],"award-info":[{"award-number":["T32AI102623"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["F31DA054849"],"award-info":[{"award-number":["F31DA054849"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes, Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["R01DK131926"],"award-info":[{"award-number":["R01DK131926"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Llura A. Gund Laboratory for Vector-borne Diseases"},{"DOI":"10.13039\/100020167","name":"Gordon and Llura Gund Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020167","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Lyme disease (LD) and babesiosis are increasing in the United States. We sought to characterize and compare their epidemiology and health burden using a nationally representative sample of hospitalizations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data were extracted from the National Inpatient Sample (NIS) pertaining to LD and babesiosis for 2018 and 2019. The NIS is a comprehensive database of all-payer inpatient hospitalizations, representing a stratified systematic random sample of discharges from US hospitals. Patient demographics, clinical outcomes, and admission costs were evaluated, in addition to hospital-level variables (eg, location\/teaching status and census division). Annual incidence of hospitalizations was calculated using US Census Bureau data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The annual incidence of hospitalizations of LD-related and babesiosis-related hospitalizations were 6.98 and 2.03 per 1 000 000 persons\/year. Of the 4585 LD hospitalizations in 2018\u20132019, 60.9% were among male patients, 85.3% were White, and 39.0% were \u226560 years. Of the 1330 babesiosis hospitalizations in 2018\u20132019, 72.2% were among male patients, 78.9% were White, and 74.1% were \u226560 years; 70.0% of LD and 91.7% of babesiosis hospitalizations occurred in Middle Atlantic or New England. Lower disease severity was noted in 81.8% of LD hospitalizations compared with 49.3% of babesiosis hospitalizations, whereas those suffering from high severity were 2.3% and 6.0%, respectively. The mean hospital charges for LD and babesiosis hospitalizations were $33 440.8 and $40 689.8, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Despite overlap between the 2 diseases, LD has a broader geographic range and a greater number of hospital admissions, whereas babesiosis is more severe, incurring longer hospital stays, higher inpatient costs, and deaths.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofac597","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T03:56:02Z","timestamp":1667879762000},"source":"Crossref","is-referenced-by-count":6,"title":["Comparing the Epidemiology and Health Burden of Lyme Disease and Babesiosis Hospitalizations in the United States"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8181-9517","authenticated-orcid":false,"given":"Evan M","family":"Bloch","sequence":"first","affiliation":[{"name":"Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Krause","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Yale School of Public Health and Yale School of Medicine , New Haven, Connecticut , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshan U","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Kate","family":"Grabowski","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Goel","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University , Baltimore, Maryland , USA"},{"name":"Department of Internal Medicine, Simmons Cancer Institute at Southern Illinois University , Springfield, Illinois , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G","family":"Auwaerter","sequence":"additional","affiliation":[{"name":"Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A R","family":"Tobian","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"2022113009500587100_ofac597-B1","article-title":"Lyme Disease","author":"Centers for Disease Control and Prevention"},{"key":"2022113009500587100_ofac597-B2","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3201\/eid2708.204763","article-title":"Comparison of Lyme disease in the United States and Europe","volume":"27","author":"Marques","year":"2021","journal-title":"Emerging Infect Dis"},{"key":"2022113009500587100_ofac597-B3","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/pathogens10111447","article-title":"The global emergence of human babesiosis","volume":"10","author":"Kumar","year":"2021","journal-title":"Pathogens"},{"key":"2022113009500587100_ofac597-B4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3201\/eid2802.210213","article-title":"Epidemiology of hospitalized patients with babesiosis, United States, 2010\u20132016","volume":"28","author":"Bloch","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2022113009500587100_ofac597-B5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/pathogens8030102","article-title":"Persistence of babesia microti infection in humans","volume":"8","author":"Bloch","year":"2019","journal-title":"Pathogens"},{"key":"2022113009500587100_ofac597-B6","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3390\/pathogens10091176","article-title":"Preventing transfusion-transmitted babesiosis","volume":"10","author":"Bloch","year":"2021","journal-title":"Pathogens"},{"key":"2022113009500587100_ofac597-B7","article-title":"Babesiosis occurrence among United States Medicare beneficiaries, ages 65 and older, during 2006\u20132017: overall and by state and county of residence","volume":"8","author":"Menis","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2022113009500587100_ofac597-B8","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1093\/cid\/ciaa1216","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America (IDSA): 2020 guideline on diagnosis and management of babesiosis","volume":"72","author":"Krause","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022113009500587100_ofac597-B9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3201\/eid2702.202728","article-title":"Use of commercial claims data for evaluating trends in Lyme disease diagnoses, United States, 2010\u20132018","volume":"27","author":"Schwartz","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2022113009500587100_ofac597-B10","doi-asserted-by":"crossref","first-page":"20160117","DOI":"10.1098\/rstb.2016.0117","article-title":"Lyme disease ecology in a changing world: consensus, uncertainty and critical gaps for improving control","volume":"372","author":"Kilpatrick","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2022113009500587100_ofac597-B11","article-title":"Ticks and tick-borne infections: complex ecology, agents, and host interactions","volume":"5","author":"Wikel","year":"2018","journal-title":"Vet Sci"},{"key":"2022113009500587100_ofac597-B12","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1242\/jeb.037564","article-title":"Challenges in predicting climate and environmental effects on vector-borne disease episystems in a changing world","volume":"213","author":"Tabachnick","year":"2010","journal-title":"J Exp Biol"},{"key":"2022113009500587100_ofac597-B13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41590-020-0648-y","article-title":"Climate change: an enduring challenge for vector-borne disease prevention and control","volume":"21","author":"Rockl\u00f6v","year":"2020","journal-title":"Nat Immunol"},{"key":"2022113009500587100_ofac597-B14","article-title":"All Patient Refined Diagnosis Related Groups (APR-DRGs) Methodology Review"},{"key":"2022113009500587100_ofac597-B15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/319742","article-title":"Severe babesiosis in long island: review of 34 cases and their complications","volume":"32","author":"Hatcher","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2022113009500587100_ofac597-B16","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/archinte.158.19.2149","article-title":"Human babesiosis in New York state: review of 139 hospitalized cases and analysis of prognostic factors","volume":"158","author":"White","year":"1998","journal-title":"Arch Intern Med"},{"key":"2022113009500587100_ofac597-B17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/525852","article-title":"Persistent and relapsing babesiosis in immunocompromised patients","volume":"46","author":"Krause","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2022113009500587100_ofac597-B18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7326\/0003-4819-155-8-201110180-00362","article-title":"Transfusion-associated babesiosis in the United States: a description of cases","volume":"155","author":"Herwaldt","year":"2011","journal-title":"Ann Intern Med"},{"key":"2022113009500587100_ofac597-B19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12941-017-0198-9","article-title":"Babesiosis in long island: review of 62 cases focusing on treatment with azithromycin and atovaquone","volume":"16","author":"Kletsova","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2022113009500587100_ofac597-B20","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMra1202018","article-title":"Human babesiosis","volume":"366","author":"Vannier","year":"2012","journal-title":"N Engl J Med"},{"key":"2022113009500587100_ofac597-B21","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1046\/j.1537-2995.2002.00251.x","article-title":"Relationship between tick bites and the seroprevalence of babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors","volume":"42","author":"Leiby","year":"2002","journal-title":"Transfusion"},{"key":"2022113009500587100_ofac597-B22","doi-asserted-by":"publisher","first-page":"ofv143","DOI":"10.1093\/ofid\/ofv143","article-title":"Geographic expansion of Lyme disease in the southeastern United States, 2000\u20132014","volume":"2","author":"Lantos","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"2022113009500587100_ofac597-B23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2664.2012.02112.x","article-title":"Predicting the speed of tick invasion: an empirical model of range expansion for the Lyme disease vector Ixodes scapularis in Canada","volume":"49","author":"Leighton","year":"2012","journal-title":"J Appl Ecol"},{"key":"2022113009500587100_ofac597-B24","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.1996.03530450047031","article-title":"Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness","volume":"275","author":"Krause","year":"1996","journal-title":"JAMA"},{"key":"2022113009500587100_ofac597-B25","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1086\/339813","article-title":"Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease","volume":"34","author":"Krause","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2022113009500587100_ofac597-B26","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/368187","article-title":"Prospective study of coinfection in patients with erythema migrans","volume":"36","author":"Steere","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2022113009500587100_ofac597-B27","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/clind\/15.6.1019","article-title":"Human babesiosis in New York state: an epidemiological description of 136 cases","volume":"15","author":"Meldrum","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2022113009500587100_ofac597-B28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac525","article-title":"Cardiac complications of human babesiosis","author":"Spichler-Moffarah","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2022113009500587100_ofac597-B29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3201\/eid1304.061035","article-title":"Human babesia microti incidence and Ixodes scapularis distribution, Rhode Island, 1998\u20132004","volume":"13","author":"Rodgers","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"2022113009500587100_ofac597-B30","article-title":"1996 HCUP Nationwide Inpatient Sample (NIS) Design Report","author":"AHRQ"},{"key":"2022113009500587100_ofac597-B31","volume-title":"Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the Seventh (2009) National Healthcare Disparities Report","author":"Coffey","year":"2009"},{"key":"2022113009500587100_ofac597-B32","doi-asserted-by":"publisher","first-page":"ofw269","DOI":"10.1093\/ofid\/ofw269","article-title":"Geographic expansion of Lyme disease in Michigan, 2000\u20132014","volume":"4","author":"Lantos","year":"2017","journal-title":"Open Forum Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofac597\/46860570\/ofac597.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/11\/ofac597\/47442447\/ofac597.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/11\/ofac597\/47442447\/ofac597.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T14:54:10Z","timestamp":1669820050000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofac597\/6809059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofac597","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,11,1]]},"article-number":"ofac597"}}